SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (573)4/6/1999 9:35:00 PM
From: smhRead Replies (1) | Respond to of 4974
 
"Let's Limbo.....How low can you go?"

So "60 Minutes" foreshadows the revolution - its only a question of time (IMO), and SUGEN sells off.... But, the whole sector???

This is pathetic. Where could capital be put to better use?
Is this the best the private sector can do? I share your frustration.

I will do my small part to put a floor under REGN tomarrow morning.
Picked up some crumbs during lunch today, BTRN @2, VICL @9 1/2. However, I am running short on "mad money." Wish I had held off on INCY.

SMH



To: scaram(o)uche who wrote (573)4/6/1999 10:36:00 PM
From: LLCFRespond to of 4974
 
< and is looking to do better by dumping a third-tier.>

Well, who's buying this stuff??? I hope it's not in the hands of "dealers"... well hell, lets see, dump my 100thou REGN @ $6 buy a few thousand .com stocks, cause as you probably saw the funds are falling way behind the [cap weighted] index's this year! Heaven forbid!!! That means you MUST BE IN THE BIGGEST CAP STOCKS...It's musical chairs baby, and theres only like 10 chairs left and 1000 mutual funds... this is going to be a fun spring... as I said 2 months ago, get your $1 bids in for a bunch of this stuff just in case! [More likely these things will go straight up]

What is happening in the market right now is imprudence to the "nth" degree by those who are paid and in some cases mandated the exact opposite. By definition if your benchmark is a cap weighted index you have to put new money to work in the stocks that go up REGARDLESS of their prospects! Pile in!

DAK

DAK



To: scaram(o)uche who wrote (573)4/7/1999 12:39:00 AM
From: margieRead Replies (1) | Respond to of 4974
 
Anyone see this feature on the ABC National News tonight “Researchers have discovered a molecular “switch” that turns off cancer cells“

abcnews.go.com

ABCNEWS.com April 6, 1999
<<In treating cancer, there are usually two options — kill the bad cells with chemotherapy or cut them out with surgery. Unfortunately, healthy cells are often destroyed in the process. But now there may be another way.

Research into the idea began on Long Island, N.Y., at the Picower Institute for Medical Research, where scientists focus on new ways to fight deadly disease. Dr. Jason Chesney was searching for a specific chemical inside human cells that fights infectious disease.
Instead, by accident, he identified another chemical, an enzyme never seen before. His discovery would make medical history.


“After months of detailed experiments, they figured out that the enzyme acts like a switch that controls a cancer cell’s ability to produce energy.
“If you can turn the switch off, if you can tell the cell to stop dividing,” Bucala says, “you can cure cancer.”

At the Picower Institute, they refer to the discovery as part of the “Warburg Paradox.” More than 70 years ago, a German biochemist named Dr. Otto Warburg discovered that cancer cells metabolize sugars without oxygen. Normal, healthy cells need oxygen for metabolism. Why cancer cells are able to skip the oxygen has been a mystery ever since Warburg’s initial discovery.

Now it looks like there’s an answer to that question. Experiments by Bucala’s staff showed that the enzyme they discovered — the molecular switch — is always turned on in cancer cells, allowing them to produce energy without oxygen.

From there, they devised an experimental cancer treatment. In the lab, Chesney displays the encouraging results. “These are human cancer cells that are untreated, and rapidly multiplying,” he says. “When we look at a second group of cells that have been treated to turn off the switch, we see that they’ve stopped multiplying and there are far fewer cells.”
It was an exciting moment. “Immediately, we knew that we had a big piece of the answer,” Bucala says, “if not the whole answer.”


The next step: animal research. They tested their experimental substance on a special breed of hairless mice that can be given human cancers. In mice that didn’t get any treatment, tumors continued to grow. But in mice that were treated, tumors shrank dramatically in just two days. It was another breakthrough.

After months of detailed experiments, they figured out that the enzyme acts like a switch that controls a cancer cell’s ability to produce energy.

“If you can turn the switch off, if you can tell the cell to stop dividing,” Bucala says, “you can cure cancer.”

But it’s important to remember that what works for mice doesn’t always work for humans. Researchers know that the hard work has really just begun

The Picower Institute has licensed its research to a drug company called Cytokine Networks Inc., which now faces the daunting task of turning this exciting discovery into a drug that cancer patients can use safely and effectively.>>

Deborah Amos ABCNews.com

Sounds promising, at least in mice, although a long way off.
Is it new? It sounds familiar.